2024Open access2cites
Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in AfricaeJHaem, Chronic Myeloid Leukemia Treatments
Active, last published 2026
In chronic lymphocytic leukemia research
Zerubabel Getahun
Kiflu
“Research focused on Chronic Lymphocytic Leukemia Research and adjacent fields.”
Addis Ababa UniversityEthiopia
Claim Your Profile1
H-index
2
Citations
Zerubabel has not officially claimed their profile. If you are Zerubabel, claim it free.
Claim Your Profile01 · About the work
What I study
erubabel Getahun Kiflu is a researcher working on Chronic Lymphocytic Leukemia Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Zerubabel's work has been cited 2 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Chronic Lymphocytic Leukemia Research×1Chronic Myeloid Leukemia Treatments×1Chemotherapy-induced organ toxicity mitigation×1
06 · Where I am
Affiliations
CurrentlyAddis Ababa University, Ethiopia
Research themes (UN SDGs)
07 · Selected work
Recent publications
Are you Zerubabel?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required